Our findings suggest that miR-200a, miR-200b, and miR-200c overexpressions are associated with the aggressive tumor progression and be recognized as reliable markers to predict the prognosis and survival in EOC patients.

Background: Enteroviruses are among the most common viruses infecting humans worldwide and they are associated with diverse clinical syndromes. Acute flaccid paralysis (AFP) is a clinical manifestation of enteroviral neuropathy, transverse myelitis, Guillian-Barre Syndrome, Traumatic neuritis and many other nervous system disorders. The objective of this study was to understand the role of Non-Polio Enteroviruses (NPEV) towards this crippling disorder.

Plant secondary metabolites constitute the most important class of natural products with diverse and valuable chemical properties and biological activities. Artemisinin, isolated from Artemisia annua L., is potentially a drug that could be effective against multidrug-resistant strains of the malarial parasite, Plasmodium. Salicylic acid (SA) acts as a potential plant growth regulator and plays an important role in regulating a number of plant physiological and biochemical processes. The present study was conducted to assess the alterations in plant growth, photosynthetic capacity, enzyme activities, and content and yield of artemisinin in Artemisia annua L. in response to foliar application of SA. Four levels of SA (0.00, 0.25, 0.50, and 1.00 mM SA) were applied on the aboveground plant parts. Plant height and dry weight were altered significantly as the level of SA increased. Besides, application of SA positively improved chlorophyll and carotenoid contents. Furthermore, significant enhancement in net photosynthetic rate (31.7%) and the activity of nitrate reductase (17.2%) and carbonic anhydrase (10.9%) was noticed as the level of SA was increased from 0.00 to 1.00 mM SA. Most importantly, the content and yield of artemisinin was positively regulated by the SA. In comparison to no SA application (control), SA at 1.00 mM increased the content and yield of artemisinin by 25.8 and 50.0%, respectively.

Our finding suggests that TP53 (Arg72Pro) polymorphism may play a significant role as risk factor for breast cancer in north Indian breast cancer patients. While MDM2 (T309G) polymorphism may not be directly associated with the risk of breast cancer occurrence in the same population, but it may play role in disease progression by triggering TP53.

MiRNA-21 is recognized as the main active candidate and high expression in many solid tumors consequential cell proliferation, differentiation, apoptosis, and closely related to metastasis of disease. The study aimed to evaluate the serum miRNA-21 expression and therapy outcome in breast cancer patients and cell lines. Seventy-five histopathologically confirmed newly diagnosed breast cancer patients were included in the study; before and after therapy, patient's blood sample were collected and analyzed for serum microRNA-21 expression by quantitative real-time PCR. In patients, 8.9 mean fold increased microRNA-21 expression was observed compared to controls. Increased expression was found to be associated with advanced stage (11.72-fold), lymph node involvement (11.12-fold), and distant metastases (20.17-fold). After treatment significant decrease in miRNA-21 expression was observed and found to be significant (p < 0.0001). Patients treated with neoadjuvant therapy had significant impact on miRNA-21 suppression and found to be significantly associated with different clinicopathological features of patients. Increased miRNA-21 expression was also found to be significantly associated with poor survival of breast cancer patients (p = 0.002). MicroRNA-21 expression could be used as promising predictive indicators for breast cancer prognosis. MicroRNA-21 over-expression was associated with response to neoadjuvant therapy and may perhaps be considered as primary treatment choice.